Evaluation of calcitonin measurement in fine needle aspirates in the diagnosis of primary and metastatic medullary thyroid carcinoma

Main Article Content

Nour El Houda Khelil Sidi Mohammed Meghelli

Abstract

Serum CT represents the tumoral marker of medullary thyroid carcinoma (MTC), and is a main diagnostic tool and follow-up after treatment. Nevertheless, calcitonin levels can be elevated in a number of other situations and does not always distinguish MTC from other clinical circumstances, particularly when elevation remains moderate. Fine needle aspiration biopsy is a widely used examination for the investigation of thyroid nodules and lymph nodes, but its sensitivity for the diagnosis of MTC remains low ranging from 45% to 63%. Calcitonin measurement in fine needle aspiration wash out fluid has been reported as reliable, and is recommended by the experts of American Thyroid Association (ATA) in their 2015 consensus for the management of MTC even if its diagnostic is not standardized yet.


Material and methods: Twenty patients with 45 lesions (thyroid nodule and lymph node) were included in this study; calcitonin was performed in each of them, the puncture needles were washed with 1ml of saline solution to obtain to measure Calcitonin in fine needle aspiration washout fluid.


Results: After surgery 32 MTC were diagnosed on histology. Receiver operating curve (ROC curve) indicated CT in fine needle aspiration >22.99pg/ml as more accurate cut off value with a sensitivity and specificity of 96.87% and 100%. Calcitonin ratio was evaluated too, the cut off value being>0.64 with a sensitivity of 62.5% and specificity of 100%.


Conclusion: Calcitonin in fine needle aspiration wash out fluid constitutes an excellent diagnostic tool of MTC with the use of 22.99pg/ml threshold.

Keywords: Medullary thyroid carcinoma, calcitonin, calcitonin in fine needle aspiration biopsy.

Article Details

How to Cite
KHELIL, Nour El Houda; MEGHELLI, Sidi Mohammed. Evaluation of calcitonin measurement in fine needle aspirates in the diagnosis of primary and metastatic medullary thyroid carcinoma. Medical Research Archives, [S.l.], v. 12, n. 2, feb. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5056>. Date accessed: 28 apr. 2024. doi: https://doi.org/10.18103/mra.v12i2.5056.
Section
Research Articles

References

1. Niccoli-Sire P, Conte-Devolx B. Cancer médullaire de la thyroïde. Ann d’Endocrinologie 2007, 68:325-331.

2. Wémeau JL. Les maladies de la thyroïde. Paris: Elservier Masson, 2010,186p. ISBN 9782294775833

3. D’herbomez M. Dosage de la calcitonine: indications et interprétations. Press med 2011, 40: 1141-1146. Doi: 10.1016/j.lpm.2011.05.026

4. D’Herbomez M, Caron P, Bauters C, Cao CD, Schlienger JL, Sapin R et al. Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age and cigarette smoking. Eur J Endocrinol 2007; 157: 749-55. doi: 10.1530/EJE-07-0566

5. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Dicos-Cio G et al. Routine measurement of serum calcitonin in nodular thyroid disease allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab. 1994; 78: 826- 829. doi: 10.1210/jcem.78.4.8157706.

6. Rieu M, Lame MC, Richard A, Lissak B, Sambort B,Vuong-Ngoc P et al. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin on the diagnostic evaluation of thyroid nodules. Clin Endocrinol. 1995; 42:453-460. doi: 10.1111/j.1365-2265.1995.tb02662.x

7. Henry JF, Denizot A, Puccini M, Gramatica L, Kvachenyuk A, Conte Devolx B, De Micco C. Latent subclinical medullary thyroid carcinoma: diagnosis and treatment. World Journal of Surgery.1998; 22:752 -756.
doi: 10.1007/s002689900464.

8. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner- Parzer S. Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 2005; 15: 1267 -1272. doi: 10.1089/thy.2005.15.1267.

9. Hahm JR, Lee MS, Min YK, Lee MK, Nam SJ, Yang JH, Chung JH. Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 2001 Jan; 11(1):73 -80. doi: 10.1089/10507250150500694.

10. Trimboli P, Cremonini N, Ceriani L, Saggiorato E, Guidoladni L, Romanelli F, Ventura C, Laurenti O, Messuti I, Solaroli E, Madaio R, Bongiovanni M, Orlandi F, Crescuzi A, Valabrega S, Giovanella L. Calcitonin measurment in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid carcinoma: a retrospective multicenter study. Clin Endocrinol (Oxf) 2014 Jan, 80(1):135- 40. doi: 10.1111/cen.12234.

11. Bugalho MJM, Santos JR, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: Fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 2005; 91:56-60.
doi: 10.1002/jso.20269.

12. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L et al. Impact of routine measurment of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10864 patients with nodular thyroid disorders. J Clin Endocrinol Métab 2004, 89(1): 163-168. doi: 10.1210/jc.2003-030550.

13. Essig GS, Poter K, Schneider D et al. Fine needle aspiration and medullary thyroid carcinoma: The risk of inadequate preoperative evaluation and initial surgery when relying up on FNA cytology alone. Endocr Pract 2013; 19(6): 920-7. doi: 10.4158/EP13143.OR.

14. Boi F, Maurelli I, Pinna G, Atzeni F, Piga M, Lai ML, Mariotti S. Calcitonin measurement in wash-out fluid from fine needle aspiration. Endocrinol Metab 2007, 92(6):2115-2118. doi: 10.1210/jc.2007-0326.

15. Diazzi C, Madeo B, Taliani E, Zirilli L, Romano S, Granata AR, De Santis MC, Simoni M, Ciani K, Carani C, Rochira V. The diagnostic value of calcitonin measurement in washout fluid from fine needle aspiration of thyroid nodules in the diagnostic of medullary thyroid cancer. Endocr Pract 2013; 19(5):769-79. doi: 10.4158/EP12420.OR.

16. Kudo T, Miyauchi A, Ito Y, Takamura Y, Amino N, Hirokawa M. Diagnosis of medullary thyroide carcinoma by calcitonin measurement in fine needle aspiration biopsy specimens. Thyroid 2007,17:635-638.
doi: 10.1089/thy.2006.0338.

17. Massaro F, Dolcino M, Dergandi R, Feronr D, Mussap M, Minuto F, Giusti M. Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone. Endocrinol Invest 2009; 32(4): 308-12. doi: 10.1007/BF03345717.

18. De Crea C, Raffaelli M, Maccora D, Carrozza C and al. Calcitonin measurement in fine- needle aspirate washout Vs cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma. ACTA Otorhinolaryngol Ital 2014; 34:399-405.

19. Zamira T. Zuraeva, Larisa V. Nikankina, Galina S. Kolesnikova, Fatima M. Abdulhabirova, Dmitriy G. Beltsevich, Natalia M. Malysheva, Alexander A. Mikheenkov. Calcitonin measurement in fine needle washout fluids in detecting medullary thyroid cancer; Problems of Endocrinology. 2023;69(3):9-15. doi: 10.14341/probl13236.

20. Asena Gokçay Canpolat, Mustafa Sahin, Koray Ceyhan, Serpil Sak, Özgür Demir, Rıfat Emral, Murat Faik Erdogan, Sevim Gullu, Demet Çorapçioglu. Calcitonin levels in washout samples vs. cytology in the detection of malignant lymphnode metastasis in recurrent medullary thyroid cancer; Turk J Med Sci (2021) 51: 3061-3066.
doi: 10.3906/sag-2105-280.

21. Trimboli P, Treglia G, Guidobaldi L, Romanelli F et al. Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin Endocrinol (Oxf). 2015 Feb;82(2):280-5. doi: 10.1111/cen.12563. Epub 2014 Aug 14. PMID:25047365. doi: 10.1111/cen.12563.

22. Pierpaolo Trimboli, Jacopo Giannelli, Bernardo Marques, Arnoldo Piccardo, Anna Crescenzi, Maurilio Deandrea. Head-to-head comparison of FNA cytology vs. calcitonin measurement in FNA washout fluids (FNA-CT) to diagnose medullary thyroid carcinoma. A systematic review and meta-analysis; Endocrine (2022) 75:33–39.
doi: 10.1007/s12020-021-02892-x.

23. Pierpaolo Trimboli, Caterina Mian, Arnoldo Piccardo, Giorgio Treglia. Diagnostic tests for medullary thyroid carcinoma: an umbrella review; Endocrine (2023) 81:183–193. doi: 10.1007/s12020-023-03326-6.

24. Mingjun Wang, Hedan Chen, Yichao Wang, Jianyong Lei, Zhihui Li. Diagnostic value and cost-effectiveness of FNA-CT versus FNAC for medullary thyroid carcinoma; Clin Endocrinol (Oxf) 2023 May;98(5):709-718.
doi: 10.1111/cen.14852. Epub 2022 Nov 23.

25. Bernardo Marques, Nuno Cunha, Raquel G. Martins, Ana Rita Elvas, Joana Couto, Jacinta Santos and al. Lymph Node Metastases of Medullary Thyroid Cancer: Role of Calcitonin in the Washout Fluid of Fine-Needle Aspiration; International Journal of Endocrinology. Apr 2020 (Vol 20); 6 pages. doi: 10.1155/2020/9267972.